Cargando…
Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes
BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascul...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706858/ https://www.ncbi.nlm.nih.gov/pubmed/36443820 http://dx.doi.org/10.1186/s12933-022-01696-1 |
_version_ | 1784840588306153472 |
---|---|
author | Wu, Zhiyuan Yu, Siqi Zhang, Haiping Guo, Zheng Zheng, Yulu Xu, Zongkai Li, Zhiwei Liu, Xiangtong Li, Xia Chen, Shuo Zhang, Jingbo Tao, Lixin Guo, Xiuhua |
author_facet | Wu, Zhiyuan Yu, Siqi Zhang, Haiping Guo, Zheng Zheng, Yulu Xu, Zongkai Li, Zhiwei Liu, Xiangtong Li, Xia Chen, Shuo Zhang, Jingbo Tao, Lixin Guo, Xiuhua |
author_sort | Wu, Zhiyuan |
collection | PubMed |
description | BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascular complication. METHODS: A total of 1870 patients of diabetes were enrolled from Beijing Health Management Cohort between 2008 and 2018 as baseline, and then followed for macrovascular complication onset. We proposed a composite risk score (0–4) by arterial stiffness severity, pool glycemic control and hypertension status. Cox model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: The mean age (SD) of this population was 59.90 (12.29) years. During a median follow-up of 4.0 years, 359 (19.2%) patients developed macrovascular complication. Compared to the normal arterial stiffness and good glycemic control group, patients with severe arterial stiffness and pool glycemic control had the highest risk of macrovascular complications (HR: 2.73; 95% CI: 1.42–5.25). Similarly, those of severe arterial stiffness and hypertension had the highest risk (HR: 2.69; 95% CI: 1.61–4.50). Patients of the composite score > 2 had a significantly increased risk of macrovascular complication. CONCLUSION: This study suggested the clinical importance of combined evaluation of arterial stiffness, glycemic control and hypertension status for the risk stratification and management of macrovascular complication of type 2 diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01696-1. |
format | Online Article Text |
id | pubmed-9706858 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-97068582022-11-30 Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes Wu, Zhiyuan Yu, Siqi Zhang, Haiping Guo, Zheng Zheng, Yulu Xu, Zongkai Li, Zhiwei Liu, Xiangtong Li, Xia Chen, Shuo Zhang, Jingbo Tao, Lixin Guo, Xiuhua Cardiovasc Diabetol Research BACKGROUND: Arterial stiffness, glycemic control and blood pressure are risk factors of macrovascular complications in type 2 diabetes. This study aimed to investigate the combined association of arterial stiffness, glycemic control and hypertension status with the occurrence of diabetic macrovascular complication. METHODS: A total of 1870 patients of diabetes were enrolled from Beijing Health Management Cohort between 2008 and 2018 as baseline, and then followed for macrovascular complication onset. We proposed a composite risk score (0–4) by arterial stiffness severity, pool glycemic control and hypertension status. Cox model was used to estimate the hazard ratio (HR) and 95% confidence interval (CI). RESULTS: The mean age (SD) of this population was 59.90 (12.29) years. During a median follow-up of 4.0 years, 359 (19.2%) patients developed macrovascular complication. Compared to the normal arterial stiffness and good glycemic control group, patients with severe arterial stiffness and pool glycemic control had the highest risk of macrovascular complications (HR: 2.73; 95% CI: 1.42–5.25). Similarly, those of severe arterial stiffness and hypertension had the highest risk (HR: 2.69; 95% CI: 1.61–4.50). Patients of the composite score > 2 had a significantly increased risk of macrovascular complication. CONCLUSION: This study suggested the clinical importance of combined evaluation of arterial stiffness, glycemic control and hypertension status for the risk stratification and management of macrovascular complication of type 2 diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-022-01696-1. BioMed Central 2022-11-28 /pmc/articles/PMC9706858/ /pubmed/36443820 http://dx.doi.org/10.1186/s12933-022-01696-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wu, Zhiyuan Yu, Siqi Zhang, Haiping Guo, Zheng Zheng, Yulu Xu, Zongkai Li, Zhiwei Liu, Xiangtong Li, Xia Chen, Shuo Zhang, Jingbo Tao, Lixin Guo, Xiuhua Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title | Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title_full | Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title_fullStr | Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title_full_unstemmed | Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title_short | Combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
title_sort | combined evaluation of arterial stiffness, glycemic control and hypertension for macrovascular complications in type 2 diabetes |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706858/ https://www.ncbi.nlm.nih.gov/pubmed/36443820 http://dx.doi.org/10.1186/s12933-022-01696-1 |
work_keys_str_mv | AT wuzhiyuan combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT yusiqi combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT zhanghaiping combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT guozheng combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT zhengyulu combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT xuzongkai combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT lizhiwei combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT liuxiangtong combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT lixia combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT chenshuo combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT zhangjingbo combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT taolixin combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes AT guoxiuhua combinedevaluationofarterialstiffnessglycemiccontrolandhypertensionformacrovascularcomplicationsintype2diabetes |